Clincosm LogoSign in Get a demo

Depressive Disorder, Treatment-Resistant

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Anergic-anhedonic Depression Open Trial

Recruiting
  • Depressive Disorder, Treatment-Resistant
    • Strasbourg, France
      CENTRE DE NEUROMODULATION NON INVASIVE DE STRASBOURG (CEMNIS) -
    Oct 25, 2023

    Drug-resistant Psychiatric Disorders Using Induced Pluripotent

    Enrolling by invitation
    • Depressive Disorder, Treatment-Resistant
      • Monza, Monza E Brianza, Italy
        Fondazione IRCCS San Gerardo di Monza
      May 24, 2023

      Depressive Disorder, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant Trial in London (Ketamine, Midazolam)

      Recruiting
      • Depressive Disorder
      • +7 more
      • London, United Kingdom
        The Institute of Psychiatry, Psychology & Neuroscience, King's C
      May 19, 2023

      Depressive Disorder, Treatment-Resistant Trial in United States (Esketamine 56 mg, Esketamine 84 mg, Placebo)

      Recruiting
      • Depressive Disorder, Treatment-Resistant
      • Esketamine 56 mg
      • +2 more
      • Birmingham, Alabama
      • +66 more
      Jan 31, 2023

      Depressive Disorder, Treatment-Resistant Trial in Edmonton, Halifax (Repetitive Transcranial Magnetic Stimulation (rTMS),

      Not yet recruiting
      • Depressive Disorder, Treatment-Resistant
      • Repetitive Transcranial Magnetic Stimulation (rTMS)
      • Repetitive Transcranial Magnetic Stimulation (rTMS) Plus Text4Support
      • Edmonton, Alberta, Canada
      • +1 more
      Dec 16, 2022

      Depression, Depressive Disorder, Treatment-Resistant, Depressive Disorder Trial in Göteborg (OSU6162, Placebo)

      Recruiting
      • Depression
      • +5 more
      • Göteborg, Västra Götaland, Sweden
        Sahlgrenska Universitetssjukhuset
      Dec 6, 2022

      Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Ketamine, Clonidine, )

      Completed
      • Depressive Disorder, Treatment-Resistant
      • Saint Louis, Missouri
        Washington University School of Medicine
      Nov 22, 2022

      Depressive Disorder, Treatment-Resistant Trial (Psilocybin-assisted psychotherapy)

      Not yet recruiting
      • Depressive Disorder, Treatment-Resistant
      • Psilocybin-assisted psychotherapy
      • (no location specified)
      Oct 12, 2022

      Depressive Disorder, Treatment-Resistant Trial in Worldwide (Esketamine Nasal Spray)

      Active, not recruiting
      • Depressive Disorder, Treatment-Resistant
      • Esketamine Nasal Spray
      • Birmingham, Alabama
      • +176 more
      Oct 12, 2022

      Depressive Disorder, Treatment-Resistant Trial in Edmonton (Repetitive Transcranial Magnetic Stimulation (rTMS),

      Completed
      • Depressive Disorder, Treatment-Resistant
      • Repetitive Transcranial Magnetic Stimulation (rTMS)
      • Internet-Delivered Cognitive Behavior Therapy (iCBT)
      • Edmonton, Alberta, Canada
        Edmonton Mental Health Clinic
      Jul 31, 2022

      Depressive Disorder, Treatment-Resistant Trial in Saint Louis (tDCS)

      Active, not recruiting
      • Depressive Disorder, Treatment-Resistant
      • tDCS
      • Saint Louis, Missouri
        Washington University in Saint Louis
      Jul 27, 2022

      Depressive Disorder, Treatment-Resistant Trial in Kaohsiung (iTBS-1800, iTBS-1200)

      Active, not recruiting
      • Depressive Disorder, Treatment-Resistant
      • iTBS-1800
      • iTBS-1200
      • Kaohsiung, Taiwan
        ChangGungMH
      May 20, 2022

      Improving Brain Stimulation Through Imaging

      Recruiting
      • Depression
      • +2 more
      • Psychological / Functional Assessment
      • +3 more
      • Palo Alto, California
        VA Palo Alto Health Care System, Palo Alto, CA
      Apr 6, 2022

      Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant Trial in Saint Louis (Nitrous Oxide 25%, Nitrous Oxide 50%,

      Completed
      Has Results
      • Depressive Disorder, Major
      • Depressive Disorder, Treatment-Resistant
      • Nitrous Oxide 25%
      • +2 more
      • Saint Louis, Missouri
        Washington University School of Medicine
      Mar 28, 2022

      Depressive Disorder, Treatment-Resistant, Depressive Disorder, Major, Unipolar Depression Trial in Montreal (Music)

      Recruiting
      • Depressive Disorder, Treatment-Resistant
      • +3 more
      • Music
      • Montreal, Quebec, Canada
      • +1 more
      Mar 22, 2022

      Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant Trial in Nashville (L-Dopa, Placebo)

      Recruiting
      • Late Life Depression
      • +4 more
      • Nashville, Tennessee
        Vanderbilt Psychiatric Hospital
      Feb 23, 2022

      Deep Brain Stimulation for Treatment-Resistant Depression

      Active, not recruiting
      • Treatment Resistant Depression
      • +2 more
      • SCC DBS
      • Lebanon, New Hampshire
        Dartmouth-Hitchcock Medical Center
      Feb 22, 2022

      Treatment-Resistant Depression Cohort in Europe

      Completed
      • Depressive Disorder, Treatment-Resistant
        • Bilzen, Belgium
        • +97 more
        Feb 2, 2022

        Depressive Disorder, Treatment-Resistant Trial in Oxford (Ebselen, Placebo)

        Recruiting
        • Depressive Disorder, Treatment-Resistant
        • Oxford, Oxfordshire, United Kingdom
          Neurosciences Building, Dept. Psychiatry, Warneford Hospital
        Dec 15, 2021

        Treatment Resistant Depression in America Latina

        Completed
        • Depressive Disorder, Treatment-Resistant
          • Ciudad Autonoma de Buenos Aires, Argentina
          • +32 more
          Dec 8, 2021

          Depressive Disorder, Treatment-Resistant Trial in Poitiers (classic rTMS using the 8-shaped coil, deep rTMS using the H1-shaped

          Recruiting
          • Depressive Disorder, Treatment-Resistant
          • classic rTMS using the 8-shaped coil
          • deep rTMS using the H1-shaped coil
          • Poitiers, France
            Centre Hospitalier Henri Laborit
          Nov 19, 2021

          Depressive Disorder, Treatment-Resistant Trial in Spain, United States (MIJ821, Placebo, Ketamine)

          Completed
          Has Results
          • Depressive Disorder, Treatment-Resistant
          • Birmingham, Alabama
          • +11 more
          Oct 7, 2021

          Depressive Disorder, Treatment-Resistant Trial in London (Naltrexone, Placebo, Ketamine)

          Recruiting
          • Depressive Disorder, Treatment-Resistant
          • London, United Kingdom
            King's College London
          Sep 28, 2021

          Depressive Disorder, Treatment-Resistant Trial in Worldwide (Esketamine, Placebo, Duloxetine (Oral Antidepressant))

          Completed
          Has Results
          • Depressive Disorder, Treatment-Resistant
          • San Diego, California
          • +68 more
          Sep 2, 2021

          Depressive Disorder, Treatment-Resistant, Depressive Disorder, Major Trial in Shanghai (Sevoflurane, Placebo)

          Not yet recruiting
          • Depressive Disorder, Treatment-Resistant
          • Depressive Disorder, Major
          • Shanghai, Shanghai, China
            Shanghai First Maternity and Infant Hospital, Tongji University
          Aug 12, 2021